These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 24120966)
1. Effects of benznidazole:cyclodextrin complexes on the drug bioavailability upon oral administration to rats. Leonardi D; Bombardiere ME; Salomon CJ Int J Biol Macromol; 2013 Nov; 62():543-8. PubMed ID: 24120966 [TBL] [Abstract][Full Text] [Related]
2. First solid-state NMR spectroscopy evaluation of complexes of benznidazole with cyclodextrin derivatives. Priotti J; Ferreira MJ; Lamas MC; Leonardi D; Salomon CJ; Nunes TG Carbohydr Polym; 2015 Oct; 131():90-7. PubMed ID: 26256164 [TBL] [Abstract][Full Text] [Related]
3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. Patel SG; Rajput SJ AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053 [TBL] [Abstract][Full Text] [Related]
5. Enhanced solubility and bioavailability of flurbiprofen by cycloamylose. Baek HH; Kwon SY; Rho SJ; Lee WS; Yang HJ; Hah JM; Choi HG; Kim YR; Yong CS Arch Pharm Res; 2011 Mar; 34(3):391-7. PubMed ID: 21547670 [TBL] [Abstract][Full Text] [Related]
6. Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis. Semalty A Expert Opin Drug Deliv; 2014 Aug; 11(8):1255-72. PubMed ID: 24909802 [TBL] [Abstract][Full Text] [Related]
7. Development of novel formulations for Chagas' disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks. Leonardi D; Salomón CJ; Lamas MC; Olivieri AC Int J Pharm; 2009 Feb; 367(1-2):140-7. PubMed ID: 18938233 [TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and evaluation of miconazole-cyclodextrin complexes for improved oral and topical delivery. Tenjarla S; Puranajoti P; Kasina R; Mandal T J Pharm Sci; 1998 Apr; 87(4):425-9. PubMed ID: 9548893 [TBL] [Abstract][Full Text] [Related]
10. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole. Taupitz T; Dressman JB; Buchanan CM; Klein S Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048 [TBL] [Abstract][Full Text] [Related]
11. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine. Rao MRP; Chaudhari J; Trotta F; Caldera F AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305 [TBL] [Abstract][Full Text] [Related]
13. Unexpected performance of physical mixtures over solid dispersions on the dissolution behavior of benznidazole from tablets. Leonardi D; Salomon CJ J Pharm Sci; 2013 Mar; 102(3):1016-23. PubMed ID: 23303640 [TBL] [Abstract][Full Text] [Related]
14. Improvement of the Ocular Bioavailability of Econazole Nitrate upon Complexation with Cyclodextrins. Abd El-Gawad AEH; Soliman OA; El-Dahan MS; Al-Zuhairy SAS AAPS PharmSciTech; 2017 Jul; 18(5):1795-1809. PubMed ID: 27830515 [TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin. Liu J; Qiu L; Gao J; Jin Y Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034 [TBL] [Abstract][Full Text] [Related]
16. Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex. Chen X; Sun X; Ren K; Zhang X; Zhang Z; Gong T Arzneimittelforschung; 2010; 60(9):571-4. PubMed ID: 21117501 [TBL] [Abstract][Full Text] [Related]
17. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies. Phillip Lee YH; Sathigari S; Jean Lin YJ; Ravis WR; Chadha G; Parsons DL; Rangari VK; Wright N; Babu RJ Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249 [TBL] [Abstract][Full Text] [Related]
18. Solving the Delivery Problems of Triclabendazole Using Cyclodextrins. Real D; Leonardi D; Williams RO; Repka MA; Salomon CJ AAPS PharmSciTech; 2018 Jul; 19(5):2311-2321. PubMed ID: 29845501 [TBL] [Abstract][Full Text] [Related]
19. Development of novel ibuprofen-loaded solid dispersion with enhanced bioavailability using cycloamylose. Baek HH; Kim DH; Kwon SY; Rho SJ; Kim DW; Choi HG; Kim YR; Yong CS Arch Pharm Res; 2012 Mar; 35(4):683-9. PubMed ID: 22553061 [TBL] [Abstract][Full Text] [Related]
20. Preparation and Characterization of Poloxamer 407 Solid Dispersions as an Alternative Strategy to Improve Benznidazole Bioperformance. Simonazzi A; Davies C; Cid AG; Gonzo E; Parada L; Bermúdez JM J Pharm Sci; 2018 Nov; 107(11):2829-2836. PubMed ID: 30005984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]